MPO and acute kidney injury: Consistently, we observed that farrerol attenuated cisplatin-induced AKI in mice by reducing the MPO and MDA levels and increasing the SOD and GSH levels compared with the levels obtained with cisplatin treatment only (Figures 7A–D).